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ABSTRACT
Cultured astrocytes exhibit a ﬂat/epitelioid phenotype much
different from the star-like phenotype of tissue astrocytes.
Upon exposure to treatments that affect the small GTPase
Rho and/or its effector ROCK, however, ﬂat astrocytes
undergo stellation, with restructuring of cytoskeleton and
outgrowth of processes with lamellipodia, assuming a phe-
notype closer to that exhibited in situ. The mechanisms of
this change are known only in part. Using the ROCK
blocker drug Y27632, which induces rapid (tens of min),
dose-dependent and reversible stellations, we focused on
two speciﬁc aspects of the process: its dependence on small
GTPases and the large surface expansion of the cells. Con-
trary to previous reports, we found stellation to be gov-
erned by the small G protein Rac1, up to disappearance of
the process when Rac1 was downregulated or blocked by a
speciﬁc drug. In contrast cdc42, the other G-protein often
involved in phenotype changes, appeared not involved. The
surface expansion concomitant to cytoskeleton restructur-
ing, also dependent on Rac1, was found to be at least par-
tially sustained by the exocytosis of enlargeosomes, small
vesicles distinct from classical cell organelles, which are
abundant in astrocytes. Exhaustion of stellation induced by
repeated administrations of Y27632 correlated with the
decrease of the enlargeosome pool. A whole-cell process like
stellation of cultured astrocytes might be irrelevant in the
brain tissue. However, local restructuring of the cytoskele-
ton coordinate with surface expansion, occurring at critical
cell sites and sustained by mechanisms analogous to those
of stellation, might be of importance in both astrocyte phys-
iology and pathology. V V C 2011 Wiley Periodicals, Inc.
INTRODUCTION
The profound structural differences between the ﬂat,
epithelioid astrocytes cultured in vitro in serum-containing
media, and the classical in-vivo star-like phenotype, with
multiple ramiﬁed processes covered with ﬁlopodia and
lamellipodia, is known since 40 years. Soon thereafter, cul-
tured astrocytes were found to reacquire at least part of
their in situ phenotype, with reduction of the cell body
and outgrowth of processes, when exposed to either dibu-
tyryl cAMP (db-cAMP) or brain extracts in serum-free me-
dium (Lin et al., 1973; Lin and Mitsunobu, 1974; Moonen
et al., 1975). The process, often named stellation, was
shown to be induced also by other agents: cGMP, adminis-
tered as the 8-bromo analogue (8Br-cGMP) or generated in
response to the atrial natriuretic peptide (Boran and Gar-
cia, 2007); AICAR, an activator of the AMP-dependent pro-
tein kinase (Favero and Mandel, 2007); interleukin 1b
(John et al., 2004); ATP (Neary et al., 1994) acting via acti-
vation of the adenosine A2 receptor (Rosso et al., 2007);
various nonsteroidal anti-inﬂammatory agents (Lichten-
stein et al., 2010); botulinum toxin C3 (Suidan et al.,
1997). Conversely, ﬂattening of stellate astrocytes was
induced not only by serum but also by thrombin and lyso-
phosphatidic acid (Holtje et al., 2005; Suidan et al., 1997).
Many aforementioned treatments were shown to operate
by affecting the small GTPase RhoA or its effector kinase,
ROCK (Favero and Mandel, 2007; John et al, 2005; Lich-
tenstein et al., 2010; Salhia et al., 2005; Suidan et al.,
1997). High Rho and ROCK activities are necessary for
ﬂattening; repression of RhoA (Boran and Garcia, 2007;
Holtje et al., 2005; John et al., 2005; Rosso et al., 2007) or
blockade of ROCK (Abe and Misawa, 2003; John et al.,
2005; Lau et al., 2011; Salhia et al., 2005) induce the con-
version of ﬂat to stellate astrocytes. The expansion or
marked reduction of the cell body accompanied by the dis-
appearance or outgrowth of branched processes, respec-
tively, are sustained by the reshaping of the cytoskeleton,
a well-known target of Rho GTPases (Hall, 2005; Ridley,
2006). Speciﬁcally, the network of thin actin ﬁlaments of
astrocytes in situ is converted in culture into a system of
robust stress ﬁbres impinging onto and running below the
plasma membrane. During stellation these ﬁbers collapse
and are converted back to the ﬁlamentous network (Favero
and Mandel, 2007; John et al., 2005; Salhia et al., 2005).
In this study, carried out by using the rapidly effective
ROCK blocker Y27632 (Abe and Misawa, 2003; John
et al., 2005; Lau et al., 2011; Salhia et al., 2005), we inves-
tigated two speciﬁc issues. The ﬁrst is whether stellation
and ﬂattening depend on Rac1, a small GTPase of the Rho
family constitutively repressed by ROCK (Nakayama
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chi et al., 2001). Rac 1 is known to govern dendritic out-
growth in various types of neural cells (Hirose et al., 1998;
Racchetti et al., 2010). In astrocytes, studies had been car-
ried out, however with conﬂicting results (John et al., 2005;
Lichtenstein et al. 2010; Rosso et al., 2007; Salhia et al.,
2005; Suidan et al., 1997). The second issue concerns the na-
ture and trafﬁcking of the membranes necessary for stella-
tion and ﬂattening to occur. The surface area of ﬂat astro-
cytes is much smaller than that of stellate astrocytes. Con-
version of one phenotype to the other requires therefore the
addition or removal of membrane to and from the plasma-
lemma (Chieregatti and Meldolesi, 2005; Morris and Homan,
2001). This trafﬁc could involve processes such as regulated
exocytosis (Chieregatti and Meldolesi, 2005), endocytosis
(Maxﬁeld and McGraw, 2004) and vesicle shedding to the
extracellular space (Cocucci et al., 2007), never investigated
in astrocytes in relation to ﬂattening and stellation.
MATERIALS AND METHODS
The mouse anti-Ahnak monoclonal antibody (mAb) was
developed in our laboratory (Borgonovo et al., 2002). Secr-
amine was the gift of T. Kirchhausen. Other Abs and
chemicals were obtained from the following sources:
mouse anti-b-tubulin mAb, rabbit anti-a actin plyclonal
Ab (pAb), DAPI, nocodazol, 8Br-cGMP, db-cAMP, ionomy-
cin, latrunculin A, wortmannin: Sigma-Aldrich; Y27632
and ionomycin: Calbiochem; rabbit anti-GFAP pAb: Dako
Cytomation; mouse anti-58K mAb: Abcam; rabbit anti-cal-
nexin pAb: Stressgen Biotech; mouse anti-TGN38 mAb:
Thermo Fischer Scientiﬁc; guinea-pig anti vGLUT1 and
anti-vGLUT2 pAbs: Chemicon; anti-EEA2 pAb: Santa
Cruz; anti-GLAST mAb: Myltenyl Biotec; mouse anti-ezrin
mAb, FITC-conjugated, TRITC-conjugated and far-red con-
jugated goat anti-mouse pAb, goat anti-rabbit pAb, FITC-
conjugated phalloidin and Lipofectamine 2000: Invitrogen;
EHT 1864: Tocris. The GFP-plasmids with scrambled or
Rac1-speciﬁc shRNA were from Origene.
Cell Culture
Primary astrocytes were obtained from the cortex of P2
Sprague-Dawley rat pups (Charles River), sacriﬁced
according an approved procedure (Prada et al, 2011).
Freshly dissected cortices were disaggregated, washed,
and seeded. After 8 days, they were depleted of microglia
by shaking and seeded again for 2 days (Prada et al.,
2011). wtPC12, PC12-27, and SH-SY5Y cells were as in
Racchetti et al. (2010). Incubation medium was MEM with
10% horse serum, reduced to 1% in the starving medium.
Cell Processing, Immunoﬂuorescence Microscopy,
and Micrometry
Cultured cells were ﬁxed in either Cytoskelﬁx (Cyto-
skeleton) (4 min at 220C) or 4% formaldehyde in phos-
phate buffer (10 min, 4C), and then washed. For tran-
sient Rac1 downregulation, the cells, seeded on slides
coated with polylysine, were exposed for 48 h to the
shRNA (Tomasoni et al., 2001), scrambled or speciﬁc.
The latter, chosen out of four based on efﬁcacy, was
as follows: CGAGGACTCAAGACAGTGTTTGATGAAGC.
Cells were then stimulated with Y27632 for 1 h and
ﬁxed in 4% formaldehyde. Processes outgrown during
t r e a t m e n tw e r ed e ﬁ n e ds ow h e nt h i n( <1 lm) and at least
5 lm long. Tissue slices 30 lmt h i c k ,o b t a i n e df r o mt h e
brain cortex of P2 rats, were ﬁxed and processed as
described by Prada et al. (2011). Whole cell and surface
immunolabelings were carried out in cells permeabilized or
not with 0.4% saponin before the ﬁrst antibody. Subse-
quent steps and recordings were as in Racchetti et al.
(2010). Quantitation of ﬂuorescence signals in either per-
meabilized or nonpermeabilized cells was made using the
IMAGEJ program (Rasband WS, ImageJ, U.S. NIH,
Bethesda, MD, http://rsb.info.nih.gov/ij/, 1997–2011). Values
given are averages 6 SD. The number and length of major
processes were estimated using the IMAGEJ program in at
least 25, Y27632-treated astrocytes for each time-point, and
then subtracted of the average baseline estimated in astro-
cytes transfected with the scrambled shRNA.
Spinning Disc Time-Lapse Imaging
Spinning disc time-lapse imaging was performed at
the IFOM-IEO campus (Milan). Astrocytes, transfected
with either the scrambled or the Rac1-speciﬁc shRNAs,
were plated at low conﬂuence on 35-mm glass-bottomed
dishes (MatTek) coated with poly-L-lysine (100 lg/mL),
then starved overnight and ﬁnally treated with Y27632
in a Nikon Ti inverted microscope (Nikon) equipped
with a Perkin Elmer Ultraview VoX spinning disc confo-
cal system (Perkin Elmer) controlled by Volocity soft-
ware (Perkin Elmer). Image sequences were converted
into avi-ﬁles with the IMAGEJ program.
Western Blotting
Western blottings were carried out and quantized as
described by D’Alessandro et al. (2008).
RESULTS
Rapid Stellation Induced by Y27632
The two panels of Fig. 1A illustrate the astrocyte phe-
notypes used for references of our studies: the star-like of
the rat brain cortex tissue (left) and the ﬂat, epithelioid
astrocytes, dissociated from brain cortex of P2 rats and
cultured for 10 days in complete, 10% serum-containing
medium (right). Fig. 1B compares the changes induced by
one of the agents previously reported to induce stellation,
8Br-cGMP (100 lM, 16 h), used here for reference. 8Br-
cGMP was administered to ﬂat astrocytes cultured in the
standard medium (left) or prestarved overnight in the me-
dium containing 1% horse serum (right).
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GLIAIn the ﬁrst case, many astrocytes maintained their ﬂat
phenotype with robust stress ﬁbers and only a few short,
thick expansions; in the second stellation appeared more
advanced, with no appreciable stress ﬁbers. Upon shorter
treatments with 8Br-cGMP the changes were less pro-
nounced, similar to those induced by db-cAMP administered
for various periods of time to prestarved cells (not shown).
When induced by Y27632, stellation was in contrast
fast and extensive, similar in both complete and low-
serum media. Upon 1 h treatment (Fig. 1C), 1 lM drug
concentration already induced changes of the astrocyte
shape from ﬂat to elongate, with reorganization of the
cytoskeleton and loss of most centrifugal stress ﬁbers. A
more advanced change, with decreased cell body area and
appearance of multiple globular surface sprouts enriched
of a-actin together with few long processes, was induced
by 10 lM drug. Twenty-ﬁve micromolars yielded fully
stellate astrocytes, with a widespread network of a-actin
Fig. 1. Astrocyte stellation induced by 8Br-cGMP and Y27632. (A)
Astrocytes of the brain tissue (left) and cultured in vitro (right) immunola-
beled for GFAP. The cells in B-E were dually immunolabeled for b-tubulin
(green) and a-actin (red). In the microscopy panels of this and the follow-
ing ﬁgures nuclei were labeled blue by DAPI. (B) astrocytes preincubated
in complete medium (left) or pre-starved overnight in low (1%) serum
medium (right) were treated with 8Br-cGMP (100 lM, 16 h). (C–E)D o s e
dependence and time-course of the phenotype changes induced by treat-
ment with Y-27632 in astrocytes. In (C), from left to right, 1 h treatment
with 0, 1, 10, and 25 lM Y27632; in (D), from left to right, 25 lM Y27632
administered for 15, 30, and 60 min. (E) Enlargement of a 60 min-treated
cells showing lamellipodia emerging from processes. (F, G) Distribution of
ezrin and GFAP in astrocytes incubated for 0 and 60 min with 25 lM
Y27632. Bars in (A) (valid in B–D and F), (E), and (G) are 10 lm. (H)
Number/cell and length of the major processes induced in populations of
at least 25 astrocytes by 30 and 60 min treatment with 25 lM Y27632.
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GLIAconcentrated at the tips of numerous, long, thin, often
branched processes (Fig. 1C). The time-course of these
effects was also investigated (Fig. 1D). A partial
reorganization of the cytoskeleton in the ﬂat cell body,
with generation of globular, a-actin-enriched surface
sprouts, was evident at 15 min; appearance of typical
processes enriched of a-actin at 30 min. At 1 h, the
cells exhibited very small bodies and many thin proc-
esses covered by lamellipodia containing a-actin (see
the high power Fig. 1E). The number and length of the
processes grown in stellating astrocytes during 60 min
treatment with 25 lM Y27632 (Fig. 1H) were analogous
of those of brain cortex astrocytes (Chao et al., 2002).
We conclude that the analogy of the Y27632-stellated
astrocytes with the star-like astrocytes of the tissue is
considerable, suggesting mechanistic commonalities in
their establishment.
Stellation induced also changes in the distribution of
the actin-binding protein ezrin. In ﬂat astrocytes, ezrin
was spread in the cytoplasm together with GFAP (Fig.
1F). Upon 1 h treatment with 25 lM Y27632, ezrin was
redistributed in part to the processes up to lamellipodia
from which GFAP was excluded (Fig. 1G). This property,
already described in tissue and cultured astrocytes by
Derouiche and Frotscher (2001), appears of functional
importance (Lavialle et al., 2011).
Role of Microtubules and Microﬁlaments
The cytoskeleton is known as a key player in the ﬂat-
tening/stellation processes (Favero and Mandel, 2007;
John et al., 2005; Salhia et al., 2005). Details about the
role of microtubules and microﬁlaments were however
still undeﬁned. Cultured astrocytes were therefore pre-
treated with either nocodazol, that induces depolymer-
ization of microtubules, or latrunculin A, that sequesters
a-actin monomers and therefore perturbs the kinetics of
microﬁlaments. The effects of these treatments were
investigated per se and in relation to the stellation
induced by 25 lM Y27632 applied together with the two
cytoskeleton-addressed drugs.
In ﬂat astrocytes, nocodazol pretreatment (30 lM, 1 h)
induced only minor changes. The drug, however, pre-
vented most changes induced by Y27632, that did not go
beyond the redistribution of a-actin with appearance of
multiple enriched surface sprouts. Outgrowth was lim-
ited to a few, thick expansions. Thus, true stellation did
not take place (Fig. 2A). The latrunculin A pretreatment
(5 lM, 15 min) failed to affect markedly the phenotype
of ﬂat astrocytes, including stress ﬁbers. It did however
change the effects of Y27632. The shape of latrunculin
A/Y27632-treated cells was variable, ranging from ﬂat
to stellate. a-Actin distribution was disordered, with
Fig. 2. Effects of nocodazol and latrunculin A on cultured astrocytes
treated or not with Y27632. The left panels of (A) and (B) show cells
treated with nocodazol (A, 30 lM, 1 h) and latrunculin A (B, 5 lM, 15
min). The central and right panels show cells that, upon treatment
with nocodazol (A) and latrunculin A (B) were further incubated with
Y27632 (25 lM, 60 min) together with the cytoskeleton-addressed
drugs. All cells were immunolabeled for b-tubulin (green) and a-actin
(red). Bar in (A), valid in (B), is 10 lm.
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GLIAformation of scattered clusters protruding from the cell
surface (Fig. 2B), while the processes exhibited only few
or no surface lamellipodia. Both cytoskeleton-addressed
drugs affect therefore stellation, however in different
ways. Nocodazol blocks process outgrowth; latrunculin A
precludes a correct reorganization of the actin network.
Stellation Induced by Y27632 Depends on Rac1
Various types of experiments were carried out to
investigate the possible Rac1-dependence of stellation.
Cultured astrocytes transfected with either the
scrambled or the Rac1-speciﬁc shRNAs positive for GFP
were treated with Y27632 (25 lM, 1 h) 48 h later. Most
cells transfected with the scrambled shRNA exhibited
the typical, Y27632-induced stellate phenotype (compare
Fig. 3A to Fig. 1C,D, right panels), with outgrowth of
multiple thin and branched processes. In contrast, in
the cells transfected with the Rac1-speciﬁc shRNAs the
changes induced by Y27632 were attenuated or com-
pletely absent (Fig. 3B).
shRNA-transfected astrocytes were also analyzed by
spinning disc time-lapse imaging upon addition of
Y27632. A comparison of the scrambled shRNA-trans-
fected cells, positive for GFP, with the GFP-negative,
nontransfected cells of the same populations, revealed
no differences, i.e. the GFP-positive and negative cells
developed concomitantly the typical stellate phenotype
induced by the drug (Fig. 3C; whole recording in Supp.
Info. Fig. 1). In contrast, in the dishes transfected with
the Rac1-speciﬁc shRNA the GFP-positive cells did not
modify signiﬁcantly their shape, whereas the GFP-nega-
tive cells underwent full stellation responses (Fig. 3D
and Supp. Info. Fig. 2).
The role of Rac1 and that of cdc42, another GTPase of
the Rho family involved in the regulation of the cyto-
skeleton (Hall, 2005; Ridley, 2006), was further investi-
gated by a pharmacological approach. Cultured astro-
cytes exposed overnight to EHT 1864 (5 lM), a Rac1
blocker with no effect on cdc42 (Shutes et al., 2007),
exhibited only minor changes of phenotype, and no stel-
lation, when exposed to Y27632 (Fig. 3E). In contrast,
most astrocytes treated with secramine (15 lM, 1 h), a
blocker of cdc42 inactive on Rac1 (Pelish et al., 2006),
exhibited Y27632-induced stellations similar to those of
control cells (Fig. 3F).
Previous evidence in a variety of cell types (reviewed
by Fukata et al., 2003) demonstrated the effects of Rac1
on the cytoskeleton to depend on its cooperation with
PI3 kinase. We therefore investigated whether the
Y27632-induced stellation was affected by wortmannin,
a blocker of the enzyme. Figure 3G shows that wortman-
nin pretreatment (0.5 lM, 1 h) induced some alteration
of the cytoskeleton with attenuation of the robust a-
actin stress ﬁbers. The subsequent application of
Y27632 failed to induce any signiﬁcant stellation. Both
the shRNA and the pharmacological results conﬁrmed
therefore that the stellation effect of Y27632 depends on
the activation of Rac1, possibly working co-ordinately
with PI3 kinase.
The Astrocyte Plasma Membrane Expansion
During Y27632-induced Stellation Is Sustained
by the Exocytosis of Enlargeosomes
By analogy to neurons and neurosecretory cells (Pfen-
ninger, 2009; Meldolesi, 2011), the astrocyte vesicles sus-
taining membrane expansion and process outgrowth
induced by Y27632 were expected to be speciﬁc, distinct
from the clear and dense-core vesicles competent for the
regulated discharge of gliotransmitters (reviewed by Par-
pura and Zorec, 2010; Volterra and Meldolesi, 2005). In
various types of neural cells (PC12, SH-SY5Y, immature
neurons) neurite outgrowth triggered by Y27632 had
been shown to be sustained by the exocytosis of enlargeo-
some (Racchetti et al., 2010), a vesicle known to be pres-
ent in cultured astrocytes (Borgonovo et al., 2002). So far,
however, the exocytosis and function of enlargeosomes in
astrocytes had never been investigated.
Western blot results in cultured, ﬂat astrocytes
revealed the expression of the enlargeosome marker,
Ahnak, to be much higher than in wtPC12 and in the
same range as other cells rich of enlargeosomes, PC12-
27 and SH-SY5Y (Fig. 4A; see Prada et al., 2011). Ahnak
immunolabeling showed the marker concentrated in
numerous small puncta spread throughout the cyto-
plasm (Fig. 4B, left panel), that upon stellation redis-
tributed also to the processes (Fig. 4B, right panel). As in
many other cell types, the Ahnak-positive puncta did not
colocalize with markers of classical organelles such as the
ER, Golgi complex, and transGolgi network (calnexin,
58K, TGN38, respectively, Fig. 4C), concentrated in dis-
crete areas of the cytoplasm. Likewise, Ahnak did not
colocalize with various glutamate transporters, neither the
clear vesicle vGLUT1 (Fig. 4D) nor the plasma membrane
transporters GLAST and EAA2, which in cultured astro-
cytes exhibited a widespread cytoplasmic distribution (not
shown). A partial colocalization of Ahnak was observed
only with the vesicular glutamate transporter vGLUT2.
Deconvolution analyses of the samples (Fig. 4E) revealed
it to occur in discrete puncta distributed in the cell body
and the processes, especially proximal to the surface. The
relevance of this colocalization remains to be investigated.
Proof of the involvement of enlargeosomes in stellation
was obtained by surface immunolabeling of nonpermea-
bilized astrocytes. As expected in view of the lumenal
localization of Ahnak, its surface immunolabeling of
resting astrocytes was negative (Fig. 5A). Treatment
with the Ca
21 ionophore ionomycin (1 lM, 10 min: Bor-
gonovo et al., 2002), induced the surface appearance of
the marker accompanied by an expansion of the plasma
membrane (Fig. 5A). The phenotype of the ionomycin-
treated cells, however, was profoundly different from
star-like. The cells remained ﬂat, with thick protrusions
much different from the thin processes of stellate cells
(Fig. 5B). Upon treatment with Y27632, in contrast, the
surface immunolabeling of Ahnak appeared concomitant
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GLIAFig. 3. Astrocyte stellation depends on Rac1. (A, B) Cultured astro-
cytes 48 hr after transient transfection of shRNA, scrambled (A) or
Rac1-speciﬁc (B), followed by treatment with Y27632 (25 lM, 60 min).
(C, D) Subsequent frames of astrocytes transfected (GFP-positive,
green) or not (GFP-negative) with the scrambled (C) or the Rac1-spe-
ciﬁc (D) shRNA, analyzed by spinning disc time-lapse imaging upon
administration of Y27632 (25 lM). The numbers on the frames of C
(valid also for D) mark the 4 min upon addition of the drug. (E–G)
Astrocytes preincubated with the speciﬁc blocker of Rac1, EHT 1864 (5
lM, overnight, E), the speciﬁc blocker of cdc42 secramine (dissolved in
1% DMSO-0.5% BSA; 15 lM, 1 h, F) or the PI3 kinase blocker, wort-
mannin (0.3 lM, 1 h, G), followed by 1 h incubation with the same
drugs without (left) or with (right; in G also the middle panel) Y27632
(25 lM). The cells of (A), (B), and (E–G) were immunolabeled for b-
tubulin (green) and a-actin (red). Bars in (A) (valid in B), (C) (valid in
D), and (E) (valid in F, G) are10 lm.
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GLIAwith stellation (compare Fig. 5D to Fig. 1H), distributed
at both the cell body and the processes, up to lamellipodia
(Fig. 5C). It was unaffected in the cells transfected with
the scrambled shRNA, and largely blocked in those trans-
fected with the shRNA speciﬁc for Rac1, which kept their
ﬂat/epithelioid phenotype unaltered (Fig. 5E). Taken to-
gether these results demonstrate that stellation induced
in astrocytes by Y27632 occurs together with strong
enlargeosome exocytic responses, also dependent on Rac1.
Repetitive Applications of Y27632 Lead to
Exhaustion of the Stellation Responses
ROCK blockade by Y27632 is reversible (Narumiya
et al., 2000). Whether in cultured astrocytes stellation
induced by the drug is dissipated on its washout and
possibly re-induced by its re-application was unknown.
Upon 1 h treatment with 25 lM Y27632, astrocytes
were therefore exposed to various times of washout
Fig. 4. Enlargeosomes participate in the surface enlargement of
stellation. (A) Western blot results showing that astrocytes are rich of
enlargeosomes (marker Ahnak, expressed in the range of enlargeosome-
rich neural cells, PC12-27 and SH-SY5Y). (B) Astrocytes before (left)
and after (right) stellation, immunolabeled for GFAP (green) and
Ahnak (red). (C) Flat cultured astrocytes dually labeled for Ahnak (red)
and markers of cytoplasmic organelles (green): calnexin for endoplasmic
reticulum (left panel), 58 K for Golgi complex (arrows, middle panel),
TGN38 for transGolgi network (arrows, right panel). (D, E) astrocytes
before (left panels) and after Y27632-induced (25 lM, 60 min) stellation
(middle panels) dually immuno-labeled for Ahnak (red) and the vesicu-
lar glutamate transporters vGLUT1 (D) and vGLUT2 (E) (green). The
right panels of (D, E) are higher magniﬁcation, deconvolved images of
the corresponding middle panels. Bars in (B) (valid in C and left/middle
panels of D, E), and in (D, E) right panels, are 10 lm.
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GLIAbefore ﬁxation and immunolabeling for a-actin and
b-tubulin. Figure 6A–C shows that 2 h washout was
enough to convert the Y27632-induced stellate cells
(Fig. 6B) into ﬂat astrocytes, with disappearance of the
processes, enlargement of the cell body, and reappear-
ance of robust stress ﬁbers (Fig. 6C). The subsequent
reapplication of the drug induced outgrowth of proc-
esses, however without major reduction of the cell body
volume and with no complete disappearance of stress
ﬁbers (Fig. 6D). A second washout yielded the reappear-
ance of the ﬂat phenotype (Fig. 6E) which was no longer
modiﬁed by subsequent applications of the drug, except
for an attenuation of stress ﬁbres (Fig. 6F).
Astrocytes used in the aforementioned studies were
immunolabeled in parallel for Ahnak to assay the total
levels of the enlargeosome marker at the various stages
of the experiment. During the initial stellation, when
the marker was largely transferred to the cell surface
(Fig. 5C), and during the ﬁrst reﬂattening, after which
the marker was mostly scatted in the cytoplasm (not
shown), the total cell levels of Ahnak remained
unchanged (Fig. 6A0-C0), suggesting the trafﬁc of enlar-
geosomes by exocytosis and endocytosis to be conserved
(Cocucci et al., 2007). However, during the second
Y27632 treatment and in the rest of the experiment the
levels decreased markedly (Fig. 6D0-F0), suggesting
losses possibly due to external surface proteolysis and/or
release of speciﬁc, Ahnak-enriched ectosomes (Cocucci
et al., 2007). In a protocol of repeated stimulations, stel-
lation appears therefore to undergo a progressive
exhaustion which may be due, at least in part, to the
exhaustion of the enlargeosome pool.
DISCUSSION
In previous studies, stellation of ﬂat cultured astro-
cytes had been induced by a variety of treatments affect-
ing the Rho/ROCK signalling. We have used one such
treatment, with the ROCK blocker Y27632. Compared to
other agents, Y27632 offers several experimental advan-
tages, i.e., stellation is dose-dependent, develops rapidly
and is rapidly reversible upon washout of the drug. We
found the ﬁrst change induced by Y27632 to be the
appearance of globular, a-actin-rich sprouts converted,
within min, into processes exhibiting microtubules in their
stalk and a-actin-rich cones at their tips. Similar to tissue
astrocytes (Derouiche and Frotscher, 2001), those induced
by Y27632 were covered by lamellipodia that exclude
GFAP, rich of a-actin and of its binding protein, ezrin.
In agreement with previous studies (Favero and Man-
del, 2007; John et al., 2005; Salhia et al., 2005), we con-
ﬁrmed stellation to depend on an extensive restructur-
ing of the cytoskeleton, involving both microtubules and
microﬁlaments. In fact nocodazol, that induces microtu-
bule depolymerization, and latrunculin A, that seques-
ters a-actin monomers, affected stellation induced by
Y27632 in different ways. The ﬁrst blocked the out-
growth of processes from the a-actin-rich sprouts
whereas the second altered the development of stellation
inducing the assembly of discrete, a-actin-rich subplas-
malemma aggregates protruding from the cell surface.
Ample evidence in a variety of cell types had shown
cytoskeletal reorganizations to depend on the small
GTPases of the Rho family, in particular on the balance
between RhoA and its effector ROCK with respect to
Fig. 5. Enlargeosome exocytosis induced by Y27632 depends on
Rac1. (A) A resting ﬂat astrocyte surface-negative for the enlargeosome
marker, Ahnak. (B) Ahnak surface-labeling in astrocyte stimulated with
ionomycin (1lM, 10 min). (C) Surface Ahnak labeling in astrocytes stel-
lated by Y27632 (25 lM, 1 h). (D) Quantitative immuno-labeling of sur-
face Ahnak labelling in groups of at least 25 cells, treated with Y27632
(25 lM) for the indicated times. (E) Ahnak surface labelling in
astrocytes transfected (see Fig. 3) with the scrambled (left) or the Rac1-
speciﬁc (right) shRNA, and then treated with Y27632 (25 lM, 1 h). Bars
in (A), valid for (B, C) left panel; (C) right panel and (E) are 10 lm.
[Color ﬁgure can be viewed in the online issue, which is available at
wileyonlinelibrary.com.]
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small GTPases governs also stellation, however, was still
an open question. RhoA activation had been shown to
induce reconversion of stellate to ﬂat cells (Suidan et al.,
1997), and inhibition of RhoA and/or of ROCK to be
needed for stellation to occur (Boran and Garcia, 2007;
Favero and Mandel, 2007; Hotje et al., 2005; John et al.,
2004; Rosso et al., 2007). Yet, results obtained by various
approaches had suggested Rac1 not to be involved (John
et al., 2004; Lichtenstein et al., 2010; Rosso et al., 2007;
Suidan et al., 1997; see however Salhia et al., 2005). The
possible role of cdc42 had never been investigated.
In other cell types, where Rac1 is constitutively inhib-
ited by ROCK, the changes of phenotype induced by
ROCK blocker drugs, such as Y27632, are known to
depend, at least in part, on the activation of Rac1 (Othta
et al., 2006; Racchetti et al., 2010; Takefui et al., 2007;
Yamaguchi et al., 2001). Our results demonstrate now
the importance of Rac1 in astrocytes. In fact, the
Y27632-induced stellation was prevented by downregu-
lation of Rac1 and blocked by EHT 1864, a speciﬁc in-
hibitor of the small GTPase, and by wortmannin, an in-
hibitor of PI3 kinase which operates co-ordinately with
Rac1 (Fukata et al., 2003). In contrast, stellation was
Fig. 6. Repeated Y27632 application/washout cycles. Effects on the
phenotype and Ahnak levels of cultured astrocytes. (A–F) Cultured
astrocytes immuno-labeled for b-tubulin (green) and a-actin (red). (A)
Before any treatment; (B) after 1 h of Y27632 (25 lM); (C) as (B) but af-
ter 2 h washout; (D) as in (C) but after 1 h reapplication of Y27632; (E)
as in D but after a second 2 h washout; (F) as in (E) but after a third 1
h application of Y27632. Bar in (A), valid in (B–F), is 10 lm. (A0–F0):
Levels of Ahnak assayed by quantitative immunolabeling in groups of
at least 25 cells each treated as in (A–F).
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Taken together our results indicate Rac1, and exclude
cdc42, as a key mediator of the stellation taking place in
cultured astrocytes upon ROCK inhibition.
Stellation induced by Y27632 requires a huge and
rapid expansion of the cell surface. Changes of this type,
no matter of the cell, can only be sustained by the exo-
cytic incorporation of intracellular membranes into the
plasma membrane (Chieregatti and Meldolesi, 2005;
Morris and Homann, 2001). The involvement of Rac1 in
the process was not surprising because the small
GTPase was already known to play stimulatory roles in
various exocytic processes inhibited by RhoA, for exam-
ple the release of insulin and catecholamines triggered
by lipid metabolism in b-cells and chromafﬁn cells,
respectively (Mamboisse et al., 2011; Wang and Thur-
mond, 2010). In these cells, however, the nature of the
exocytic organelles involved had not been identiﬁed,
except for their distinction from the vesicles of transmit-
ter release (Alberts et al., 2006). Our novel ﬁnding was
the identiﬁcation of enlargeosomes, small vesicles com-
petent for regulated exocytosis abundant in many cells
including astrocytes (Borgonovo et al., 2002), as the or-
ganelles that participate in stellation. In addition to
their rapid discharge induced by large increases of the
cytosolic Ca
21 concentration (Borgonovo et al., 2002;
Kasai et al., 1999), enlargeosomes of neural cell types
had been shown to undergo slower, Ca
21-independent
exocytoses upon Y27632 treatment, with ensuing surface
enlargement and outgrowth of neurites (Racchetti et al.,
2010). However, in non-neural cells such as HeLa and
ﬁbroblasts, also rich of enlargeosomes, Y27632-induced
discharge occurs without signiﬁcant changes of the cell
shape (Racchetti et al., 2010). We have now shown that
in astrocytes discharge of enlargeosomes, induced by
Y27632 via the activation of Rac1, is essential for a pro-
found phenotypic change such as stellation. Down-regu-
lation of Rac1 prevented in fact not only stellation but
also enlargeosome exocytosis. Finally, in experiments
carried out according to a repeated Y27632 administra-
tion-washout protocol, stellation responses were progres-
sively reduced and then exhausted in parallel to partial
depletion of the enlargeosome pools of the cells. Taken to-
gether our results strongly suggest that, although neces-
sary, neither the speciﬁc cytoskeleton restructuring, nor
surface enlargement of the cell are sufﬁcient to induce
stellation that requires the concomitant, Rac1-dependent
stimulation of both processes.
Flattening/stellation are overall phenotype changes
taking place in cultured astrocytes which might be irrel-
evant for astrocytes in the brain. Astrocytes, however,
are not static but move in the brain tissue, a function
that requires cytoskeleton reorganization in discrete cell
areas and membrane trafﬁc to and from plasma mem-
brane domains. In addition, astrocytes are able to adjust
their structure/function depending on the activity of the
surrounding cells. Local retractions/expansions of the
astrocyte laminae ensheating various portions of
neurons (Theodosis et al., 2008) modify the geometry of
the extracellular space and are known to participate in
multiple brain functions including synaptic plasticity
(Lavialle et al., 2011; Reichembach et al., 2011). Plastic-
ity of astrocytes themselves, often dependent on their
interaction with microglia, is particularly relevant under
pathological conditions (Zhang et al., 2010). Although
speciﬁc studies have not been carried out yet, it is possi-
ble that mechanisms that sustain the ﬂattening/stella-
tion of cultured astrocytes participate also in the local
astrocyte plasticity in situ and may therefore play signif-
icant roles in the physiology and pathology of the brain.
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